Global & regional market size forecasts through 2035. Competitive benchmarking and SWOT analysis of top providers. Segmentation insights. Regulatory and sustainability landscape ...

("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and ...

Using a deep learning AI model, researchers identified the first-of-its-kind biomarker of chronic stress detectable through routine imaging, according to research being presented next week at the ...

The shape of the gluteus maximus muscle in the buttocks changes in different ways with aging, lifestyle, frailty, osteoporosis and type 2 diabetes, and these changes differ between women and men, ...

Is your coffee cup toxic? Discover how plastic-coated disposable cups may release chemicals that affect hormones, gut health and long-term wellness.

PRNewswire/ -- "I'm a board-certified nurse practitioner and wound care provider, and I wanted to create a topical treatment to help heal acute and chronic wounds," said an inventor, from San Antonio, ...

Most common conditions are tension-type headache, migraine and diabetic neuropathy Highlights: A new systematic analysis shows more than half the people living in the U.

Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, today announces it has ...

The study published in the Journal of Translational Medicine examined whether a root canal treatment to treat apical periodontitis (AP) – an inflammatory condition often caused ...

New subgroup analysis from the Phase 3 monarchE trial that explores outcomes by nodal status for Verzenio plus endocrine therapy in HR+, HER2– high-risk early breast cancer INDIANAPOLIS, Nov. 24, 2025 ...

Green kiwifruit naturally eases constipation with its unique fibre blend, enzymes, and gut-friendly effects-offering gentle, daily relief for FGIDs.

Real-world analysis reveals that glucagon-like peptide-1 receptor agonists provide cardiovascular benefits for adults with type 2 diabetes. Glucagon-like peptide-1 receptor agonists reduce major ...